Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis

BACKGROUND: Although short-term efficacy of lumacaftor/ivacaftor and tezacaftor/ivacaftor is clearly established in clinical trials, data on long-term effectiveness is limited. This registry-based cohort study assessed real-world longitudinal outcomes of F508del-homozygous people with cystic fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Muilwijk, Danya, Zomer-van Ommen, Domenique D., Gulmans, Vincent A.M., Eijkemans, Marinus J.C., van der Ent, Cornelis K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661249/
https://www.ncbi.nlm.nih.gov/pubmed/36382237
http://dx.doi.org/10.1183/23120541.00204-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661249/
https://www.ncbi.nlm.nih.gov/pubmed/36382237
http://dx.doi.org/10.1183/23120541.00204-2022

Ejemplares similares